This article examines the current operational landscape of biosimilar clinical drug development and identifies opportunities to decrease the risks associated with increasing competition. With an …
Regina Ballinger and Deborah Komlos from Thomson Reuters are submitting an interesting editorial titled FDA Makes First Move on Biosimilars in the US, and they …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
